CRAIG RICK TRAVIS, MD
Osteopathic Medicine at 87 St, Miami, FL

License number

Florida ME0061165

Personal information

See more information about CRAIG RICK TRAVIS at radaris.com

Name

Address

Phone

Craig Travis, age 79

5901 SW 87Th St, Miami, FL 33143

(305) 668-9877

Craig Travis, age 71

250 NW 40Th Ave, Delray Beach, FL 33445

(561) 496-5573

Craig R Travis, age 79

5901 87Th St, South Miami, FL 33143

(305) 668-9877

Craig & Travis Prescott

Gainesville, FL

(352) 377-2257

Craig Travis

Miami, FL

(305) 668-9877

Professional information

See more information about CRAIG RICK TRAVIS at trustoria.com

President At Immugen Pharmaceuticals, Inc.

Position:

Founder at Immugen Pharmaceuticals, Inc., Managing Director at Beachcliff Resorts, Inc.

Location:

Miami/Fort Lauderdale Area

Industry:

Biotechnology

Work:

Immugen Pharmaceuticals, Inc. - Founder Beachcliff Resorts, Inc. since 1998 - Managing Director Immugen Pharmaceuticals, Inc. May 1999 - May 2012 - President

Education:

Chicago Medical School at Rosalind Franklin U-Med & Science 1972 - 1976
MD, Medicine

Skills:

Healthcare, Biotechnology, Entrepreneurship, Lifesciences, Clinical Research, Hospitals, Emergency Medicine

Interests:

Cannabinoid research, particularly with non-psychoactive compounds which can modify the immune response.

Dr. Craig R Travis, South Miami FL - MD (Doctor of Medicine)

Specialties:

Emergency Medicine

Address:

5901 SW 87Th St, South Miami 33143
(305) 668-9877 (Phone)

Certifications:

Emergency Medicine, 2006

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School

Alkylated Resorcinol Derivatives For The Treatment Of Immune Diseases

US Patent:

6274635, Aug 14, 2001

Filed:

Mar 22, 2000

Appl. No.:

9/533386

Inventors:

Craig A. Travis - South Miami FL

Assignee:

Immugen Pharmaceuticals Inc. - Miami FL

International Classification:

C07C 3912, C07C 3900, C07C 4100, A01N 3100, A01N 4316

US Classification:

514885

Abstract:

The present invention provides a method, compounds, and compositions for treating a disease associated with immune dysfunction. In accordance with the method, a pharmacologically-acceptable composition including at least one compound selected from the group of compounds consisting of 5-alkyl-resorcinol derivatives, cannabinol derivatives, cannabidiol derivatives, cannabigerol derivatives, and combinations thereof is administered to a patient under conditions sufficient to attenuate the dysfunction within the immune system. The invention also provides an antiviral cannabinol derivative that can be used in the inventive method. The invention also provides an alkylated resorcinol derivative and a method of using the alkylated resorcinol derivative to attenuate the growth of a neoplasm. The method and compound are useful for treating diseases of the immune system, such as HIV disease and neoplastic disorders.

Methods And Compounds For Inhibiting Eicosanoid Metabolism And Platelet Aggregation

US Patent:

2002013, Sep 26, 2002

Filed:

Sep 28, 2001

Appl. No.:

09/967353

Inventors:

Craig Travis - South Miami FL, US

International Classification:

A61K031/05

US Classification:

514/731000, 435/002000

Abstract:

The invention provides a method for attenuating the aggregation and/or activation of blood platelets within a blood product. In accordance with this method, a cannabinoid or resorcinolic compound is introduced into the blood product under conditions sufficient to inhibit the aggregation and/or activation of blood platelets within the blood product. The invention also pertains to the use of a cannabinoid or resorcinolic compound to prepare a composition suitable for inhibiting the activation and/or aggregation of blood platelets and to such compositions. The invention also pertains to a method of selectively inhibiting COX-1 and thromboxane synthase within a cell or blood platelet.

Topical Formulations Of Resorcinols And Cannibinoids And Methods Of Use

US Patent:

2003023, Dec 18, 2003

Filed:

Mar 18, 2003

Appl. No.:

10/391845

Inventors:

Craig Travis - South Miami FL, US

Assignee:

Immugen Pharmaceuticals, Inc. - South Miami FL

International Classification:

A61K031/353, A61K035/78

US Classification:

424/776000, 514/455000, 514/454000

Abstract:

In one aspect, the invention provides a method for preventing the transmission of HIV from one individual to another. In accordance with the method, a pharmacologically-acceptable composition including at least one resorcinol derivative compound and/or cannabinoid (e.g., cannabinol derivatives, 8-THC derivatives, cannabichromene derivatives, cannabidiol derivatives, cannabigerol derivatives) (including combinations thereof) is administered topically to a first individual harboring HIV, or to a second individual at risk of infection with HIV, proximate in time with contact between the first individual and the second individual. The invention also provides topical formulations of at least one resorcinol and/or cannabinoid and water insoluble polymers as hydrogels.

Antiviral Methods And Compounds

US Patent:

2003017, Sep 11, 2003

Filed:

Jan 16, 2003

Appl. No.:

10/345714

Inventors:

Craig Travis - South Miami FL, US

Assignee:

Immugen Pharmaceuticals, Inc. - South Miami FL

International Classification:

A61K031/5377, A61K031/382, A61K031/353

US Classification:

514/233500, 514/312000, 514/432000, 514/456000, 544/145000, 544/151000, 546/153000, 549/023000, 549/399000

Abstract:

The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.